Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors

Annals of the New York Academy of Sciences

Volumn 872, Issue , 1999, Pages 142-163

  Broxmeyer, Hal E ^a,b   Kim, Chang H ^a,b   Cooper, Scott H ^a,b   Hangoc, Giao ^a,b   Hromas, Robert ^a,b   Pelus, Louis M ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; EOTAXIN; GAMMA CHEMOKINE; GROWTH FACTOR; INTEGRIN; LYMPHOTACTIN; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RECOMBINANT PROTEIN;

BONE MARROW CELL; BONE MARROW SUPPRESSION; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL SUBPOPULATION; CHEMOTAXIS; COLONY FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PROMYELOCYTE;

EID: 0033001177     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08460.x     Document Type: Conference Paper

References (57)

1. BROXMEYER, H.E. 1998. The hematopoietic system: Principles of therapy with hematopoietically active cytokines. In Cytokines in the Treatment of Hematopoietic Failure. A. Ganser & D. Hoelzer, Eds.: 1-37. Marcel Dekker. New York.
2. BAGGIOLINI, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568.
3. MURPHY, P.M. 1996. Chemokine receptors: Structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7: 47-64.
4. ROLLINS, B.J. 1997. Chemokines, Blood 90: 909-928.
5. BAGGIOLINI, M., B. DEWALD & B. MOSER. 1997. Human chemokines: An update. Annu. Rev. Immunol. 15: 675-705.
6. BROXMEYER, H.E. & C.H. KIM. 1998. Chemokines and hematopoiesis. In Chemokines and Cancer. B.J. Rollins, Ed. Humana Press, Totowa, NJ. In press.
7. KIM, C.H. & H.E. BROXMEYER. 1998. Chemokines for immature blood cells: Effects on migration, proliferation and differentiation. In Chemokines and Diseases. M.E. Rothenberg, Ed. Marcel Dekker. New York. In press.
8. BROXMEYER, H.E., B. SHERRY, L. LU, S. COOPER, C. CAROW, S.D. WOLPE & A. CERAMI. 1989. Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 in vitro on colony formation by murine and human bone marrow granulocyte-macrophage progenitor cells. J. Exp. Med. 170: 1583-1594.
9. BROXMEYER, H.E., B. SHERRY, L. LU, S. COOPER, K.-O. OH, P. TEKAMP-OLSON, B.S. KWON & A. CERAMI. 1990. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76: 1110-1116.
10. GRAHAM, G.J., E.G. WRIGHT, R. HEWICK, S.D. WOLPE, N.M. WILKIE, D. DONALDSON, S. LORIMORE & I.B. PRAGNELL. 1990. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344: 442-444.
11. BROXMEYER, H.E., B. SHERRY, S. COOPER, F.W. RUSCETTI, D.E. WILLIAMS, P. AROSIO, B.S. KWON & A. CERAMI. 1991. Macrophage inflammatory protein (MIP)-1b abrogates the capacity of MIP-1a to suppress myeloid progenitor cell growth. J. Immunol. 147: 2586-2594.
12. BROXMEYER, H.E., B. SHERRY, S. COOPER, L. LU, R. MAZE, M.P. BECKMANN, A. CERAMI & P. RALPH. 1993. Comparative analysis of the suppressive effects of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J. Immunol. 150: 3448-3458.
13. MANTEL, C., Y.-J. KIM, S. COOPER, B. KWON & H.E. BROXMEYER. 1993. Polymerization of murine macrophage inflammatory protein-1a inactivates its myelosuppressive effects in vitro. The active form is monomer. Proc. Natl. Acad. Sci. USA 90: 2232-2236.
14. BROXMEYER, H.E., S. COOPER, N. HAGUE, L. BENNINGER, A. SARRIS, K. CORNETTA, S. VADHAN-RAJ, P. HENDRIE & C. MANTEL. 1995. Human chemokines: Enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor dependent cell line and in vivo in mice. Ann. Hematol. 71: 235-246.
15. +++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp. Hematol. 21: 1442-1446.
16. CLEMENTS, J.M., S. CRAIG, A.J.H. GEARING, M.G. HUNTER, C.M. HEYWORTH, T.M. DEXTER & B.I. LORD. 1992. Biological and structural properties of MIP-1α expressed in yeast. Cytokine 4: 76-82.
17. GRAHAM, G.J., M.G. FRESHNEY, D. DONALDSON & I.B. PRAGNELL. 1992. Purification and biochemical characterisation of human and murine stem cell inhibitors (SCI). Growth Factors 7: 151-160.
18. KELLER, J.R., S.H. BARTELMEZ, E. SITNICKA, F.W. RUSCETTI, M. ORTIZ, J.M. GOOYA & S.E.W. JACOBSEN. 1994. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 84: 2175-2181.
19. + cells purified from cord blood and fetal liver. Exp. Hematol. 23: 422-427.
20. SU, S.B., N. MUKAIDA, J.B. WANG, Y. ZHANG, A. TAKAMI, S. NAKAO & K. MATSUSHIMA. 1997. Inhibition of immature erythroid progenitor cell proliferations by macrophage inflammatory protein-1α by interacting mainly with a C-C chemokine receptor, CCR1. Blood 90: 605-611.
21. MAZE, R., B. SHERRY, B.S. KWON, A. CERAMI & H.E. BROXMEYER. 1992. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J. Immunol. 149: 1004-1009.
22. COOPER, S., C. MANTEL & H.E. BROXMEYER. 1994. Myelosuppressive effects in vivo with very low dosage of monomeric recombinant murine macrophage inflammatory protein-1α. Exp. Hematol. 22: 186-193.
23. HUNTER, M.G., L. LAWDEN, D. BROTHERTON, S. CRAIG, S. CRIBBES, L.G. CZAPLEWSKI, T.M. DEXTER, A.H. DRUMMOND, A.H. GEARING, C.M. HEYWORTH, B.I. LORD, M. MCCOURT, P.G. VARLEY, L.M. WOOD, R.M. EDWARDS & P.J. LEWIS. 1995. BB-10010: An active variant of human macrophage inflammatory protein-1α with improved pharmaceutical properties. Blood 86: 4400-4408.
24. BROXMEYER, H.E., A. ORAZI, N.L. HAGUE, G.W. SLEDGE, JR., H. RASMUSSEN & M.S. GORDON. 1998. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1α, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cells Mol. Dis. 24:14-30.
25. DALY, T.J., G.I. LAROSA, S. DOLICH, T.E. MAIONE, S. COOPER & H.E. BROXMEYER. 1995. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J. Biol. Chem. 270: 23282-23292.
26. HROMAS, R., P.W. GRAY, D. CHANTRY, M. KRATHWOHL, K. FIFE, G.I. BELL, I. TAKEDA, S. ARONICA, M. GORDON, S. COOPER, H.E. BROXMEYER & M. KLEMSZ. 1997. Cloning and characterization of exodus, a novel b-chemokine. Blood 89: 3315-3322.
27. HROMAS, R., C.H. KIM, M. KLEMSZ, M. KRATHWOHL, K. FIFE, S. COOPER, C. SCHNIZLEIN-BICK & H.E. BROXMEYER. 1997. Isolation and characterization of exodus-2, a novel C-C chemokine with a unique 37 amino acid carboxy terminal extension. J. Immunol. 159: 2554-2558.
28. SARRIS, A.H., H.E. BROXMEYER, U. WIRTHMUELLER, N. KARASAVVAS, J. KRUEGER & J.V. RAVETCH. 1993. Human interferon inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. 178: 1127-1132.
29. YOUN, B.S., I.-K. JANG, H.E. BROXMEYER, S. COOPER, N.A. JENKINS, D.J. GILBERT, N.G. COPELAND, T.A. ELICK, M.J. FRASER, JR. & B.S. KWON. 1995. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors. J. Immunol. 155: 2661-2667.
30. YOUN, B.S., S.M. ZHANG, E.K. LEE, D.H. PARK, H.E. BROXMEYER, P.M. MURPHY, M. LOCATI, J.E. PEASE, K.K. KIM, K. ANTOL & B.S. KWON. 1997. Molecular cloning of leukotactin-1: A novel human b-chemokine, a chemoattractant for neutrophils, monocytes and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J. Immunol. 159: 5201-5205.
31. YOUN, B.S., S.M. ZHANG, H.E. BROXMEYER, S. COOPER, K. ANTOL, M. FRASER & B.S. KWON. 1998. Characterization of CKβ-8 and CKβ8-1: Two alternatively spliced forms of human β-chemokine, chemoattractants for neutrophils, monocytes and lymphocytes, and potent agonists at CC chemokine receptor 1. Blood 91: 3118-3126.
32. YOUN, B.S., S. ZHANG, H.E. BROXMEYER, K. ANTOL, M.J. FRASER, JR., G. HANGOC & B.S. KWON. 1998. Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine with myelosuppressive activity. Biochem. Biophys. Res. Commun. 247: 217-222.
33. BROXMEYER, H.E., S. COOPER, Z.H. LI, L. LU, A. SARRIS, M.H. WANG, C. METZ, M.S. CHANG, D.B. DONNER & E.J. LEONARD. 1996. Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Ann. Hematol. 73: 1-9.
34. KIM, C.H., L.M. PELUS, E. APPELBAUM, K. JOHANSON & H.E. BROXMEYER. 1998. Functional comparision of the two ligands of CC chemokine receptor CCR7, SLC/6Ckine/Exodus 2 and CKβ-11/MIP-3β/ELC. Submitted for publication.
35. GEWIRTZ, A.M., B. CALABRETTA, B. RUCINSKI, S. NIEWIAROWSKI & W.Y. XU. 1988. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J. Clin. Invest. 83: 1477-1486.
36. GEWIRTZ, A.M., J. ZHANG, J. RATAJCZAK, M. RATAJCZAK, K.S. PARK, C. LI, Z. YAN & M. PONCZ. 1995. Chemokine regulation of human megakaryocytopoiesis. Blood 86: 2559-2567.
37. HAN, Z.C., L. SENSEBE, J.F. ABGRALL & J. BRIERE. 1990. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 75: 1234.
38. PATEL, V.P., B.L. KREIDER, Y. LI, H. LI, K. LEUNG, T. SALCEDO, B. NARDELLI, V. PIPPALLA, S. GENTZ, R. THOTAKURA, D. PARMELEE, R. GENTZ & G. GAROTTA. 1997. Molecular and functional characterization of two novel human CC chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 185: 1163-1172.
39. SANCHEZ, X., K. SUETOMI, B. COUSINS-HODGES, J.K. HORTON & J. NAVARRO. 1998. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2. J. Immunol. 160: 906-910.
40. + human bone marrow cells. J. Immunol. 159: 895-904.
41. + progenitors to peripheral blood. J. Exp. Med. 185: 111-120.
42. KIM, C.H. & H.E. BROXMEYER. 1998. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: Stromal cell-derived factor-1, steel factor and the bone marrow environment. Blood 91: 100-110.
43. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91: 4523-4530.
44. KIM, C.H., L.M. PELUS, J.R. WHITE & H.E. BROXMEYER. 1998. CKb-11/MIP-3b/ELC, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors amongst myeloid progenitor cells. J. Immunol. 161: 2580-2585.
45. COOPER, S. & H.E. BROXMEYER. 1996. Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent co-stimulating cytokines steel factor and Flt-3 ligand. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, W. Strober & R. Coico, Eds. Suppl 18: 6.4.1-6.4.12. John Wiley & Sons, Inc. New York.
46. DUNLOP, D.J., E.G. WRIGHT, S. LORIMORE, G.J. GRAHAM, T. TOLYOAKE, D.J. KERR, S.D. WOLPE & I.B. PRAGNELL. 1992. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP-1α in vivo. Blood 79: 2221-2225.
47. LORD, B.I., T.M. DEXTER, J.M. CLEMENTS, M.A. HUNTER & A.J.H. GEARING. 1992. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79: 2605-2609.
48. BROXMEYER, H.E., S. COOPER, T. MAIONE, M. GORDON & T. DALY. 1995. Myeloprotective effects of the chemokines interleukin-8 and platelet factor 4 in a mouse model of cytosine arabinoside (ARA-C) chemotherapy [abstract]. Exp. Hematol. 23: 900.
49. HAN, Z.C., M. LU, J. LI, M. DEFARD, B. BOVAL, N. SCHLEGEL & J.P. CAEN. 1997. Platelet-factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood 89: 2328-2335.
50. BROXMEYER, H.E., S. COOPER, G. CACALANO, N.L. HAGUE, E. BAILISH & M.W. MOORE. 1996. Interleukin-8 receptor is involved in negative regulation of myeloid progenitor cells in vivo: Evidence from mice lacking the murine IL-8 receptor homolog. J. Exp. Med. 184: 1825-1832.
51. BORING, L., J. GOSLING, S.W. CHENSUE, S.L. KUNKEL, R.V. FARESE, JR., H.E. BROXMEYER & I.F. CHARO. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100: 2552-2561.
52. REID, S., A. RITCHIE, L. BORING, S. COOPER, G. HANGOC, I.F. CHARO & H.E. BROXMEYER. 1999. Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood. In press.
53. BROXMEYER, H.E., S. COOPER, G. HANGOC, J.L. GAO & P.M. MURPHY. 1997. Chemokine receptor CCR1 acts as a dominant receptor for MIP-1a enhancement of proliferation of mature progenitors in vitro, MIP-1a mobilization of progenitors in vivo, and MIP-1a enhancement of G-CSF induced mobilization, but not for MIP-1a suppression of immature progenitors in vitro: Effects elucidated using CCR1 knock-out mice [abstract]. Blood 90 (Suppl. 1, Part 1): 571a.
54. TAKAHIRA, H., A. GOTOH, A. RITCHIE & H.E. BROXMEYER. 1997. Steel factor enhances integrin-mediated tyrosine phosphorylation of focal adhesion kinase (pp125FAK) and paxillin. Blood 89: 1574-1584.
55. GOTOH, A., H. TAKAHIRA, R.L. GEAHLEN & H.E. BROXMEYER. 1997. Cross-linking of integrins induces tyrosine phosphorylation of proto-oncogene product vav and protein tyrosine kinase Syk in a human factor-dependent myeloid cell line. Cell Growth & Differ. 8: 721-729.
56. GOTOH, A., A. RITCHIE, H. TAKAHIRA & H.E. BROXMEYER. 1997. Thrombopoietin and erythropoietin activate inside-out signal of integrin and enhance adhesion to immobilized fibronectin in human growth-factor-dependent hematopoietic cells. Ann. Hematol. 75: 207-213.
57. SHIBAYAMA, H., N. ANZAI, A. RITCHIE, S. ZHANG, C. MANTEL & H.E. BROXMEYER. 1998. Interleukin-3 and Flt3-ligand induce adhesion of Baf3/Flt3 precursor B-lymphoid cells to fibronectin via activation of VLA-4 and VLA-5. Cell. Immunol. 187: 27-33.